Intercept Pharmaceuticals, Inc. (ICPT)

Nov 8, 2023 - ICPT was delisted (reason: acquired by Alfasigma)

19.00

0.00 (0.00%)

Inactive · Last trade price on Nov 7, 2023

Intercept Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year	TTM	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Sep '23 Sep 30, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018
Cash & Equivalents	102.74	50.52	84.71	58.15	70.06	43.25
Short-Term Investments	219.98	435.05	334.98	411.52	582.57	392.91
Cash & Short-Term Investments	322.71	485.57	419.69	469.67	652.62	436.16
Cash Growth	-34.25%	15.70%	-10.64%	-28.03%	49.63%	5.12%
Accounts Receivable	32.48	26.86	28.34	41.55	38.04	25.69
Other Receivables	1.1	2.4	1.3	2.5	-	-
Receivables	33.58	29.26	29.64	44.05	38.04	25.69
Prepaid Expenses	26.23	19.96	21.48	24.52	25.92	20.57
Restricted Cash	0.92	5.34	8.12	7.5	4.73	-
Other Current Assets	-	-	29.1	-	-	-
Total Current Assets	383.45	540.13	508.02	545.74	721.32	482.43
Property, Plant & Equipment	0.82	0.99	3.28	18.65	18.45	10.41
Other Long-Term Assets	8.9	12.6	15.72	16.1	15.12	16.33
Total Assets	393.16	553.71	527.02	580.49	754.89	509.17

Liabilities

Fiscal Year	TTM	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Sep '23 Sep 30, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018
Accounts Payable	10.27	14.23	17.6	24.59	18.98	11.77
Accrued Expenses	76.49	101.6	92.21	135.79	130.54	94.16
Current Portion of Long-Term Debt	-	109.57	-	-	-	-
Current Portion of Leases	-	-	-	7.25	6.46	-
Current Income Taxes Payable	2.87	3.14	-	-	-	-
Current Unearned Revenue	-	-	-	-	-	1.62
Other Current Liabilities	1.22	1.53	58.36	11.45	6.04	6.66
Total Current Liabilities	90.85	230.08	168.16	179.08	162.01	114.21
Long-Term Debt	223.86	223.1	539.78	560.58	532.08	371.25
Long-Term Leases	-	-	-	7.68	9.22	-
Long-Term Unearned Revenue	-	-	-	-	-	0.81
Other Long-Term Liabilities	6.62	7.45	3.04	-	0.03	3.77
Total Liabilities	321.32	460.63	710.99	747.34	703.33	490.04

Shareholders' Equity

Fiscal Year	TTM	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Sep '23 Sep 30, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018
Common Stock	0.04	0.04	0.03	0.03	0.03	0.03
Additional Paid-In Capital	2,257	2,238	2,309	2,234	2,176	1,800
Retained Earnings	-2,178	-2,137	-2,490	-2,398	-2,123	-1,779
Comprehensive Income & Other	-7.2	-8.26	-2.87	-2.48	-1.14	-2.26
Shareholders' Equity	71.85	93.08	-183.96	-166.85	51.56	19.13
Total Liabilities & Equity	393.16	553.71	527.02	580.49	754.89	509.17

Additional Metrics

Fiscal Year	TTM	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Sep '23 Sep 30, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018
Total Debt	223.86	332.67	539.78	575.51	547.76	371.25
Net Cash (Debt)	98.86	152.89	-120.09	-105.85	104.87	64.91
Net Cash Growth	-34.64%	-	-	-	61.56%	9.57%
Net Cash Per Share	2.37	4.52	-3.77	-3.21	3.31	2.28
Filing Date Shares Outstanding	41.83	41.67	29.69	33.02	32.85	29.69
Total Common Shares Outstanding	41.81	41.52	29.57	33.02	32.85	29.69
Working Capital	292.6	310.05	339.86	366.67	559.31	368.22
Book Value Per Share	1.72	2.24	-6.22	-5.05	1.57	0.64
Tangible Book Value	71.85	93.08	-183.96	-166.85	51.56	19.13
Tangible Book Value Per Share	1.72	2.24	-6.22	-5.05	1.57	0.64
Machinery	1.76	4.39	8.52	9.97	8.42	7.89
Leasehold Improvements	0.4	0.4	12.88	13.24	10.49	14.46

SEC Filings: 10-K · 10-Q